Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short

Blackhawks Comeback Falls Short; Lose To Oilers In OT

The Chicago Blackhawks and Edmonton Oilers put on a late-night show at United Center. It had quite the finish.

Yahoo Sports - 14h

Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs

Ozempic and Wegovy maker Novo Nordisk quieted Wall Street's concerns with its fourth-quarter results and 2025 outlook.

CNBC - 23h

Chipotle earnings beat estimates, but stock falls on weak same-store sales forecast

Chipotle earnings beat estimates as restaurant traffic rises again.

CNBC - 1d

Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off

The results cap off a critical year for Pfizer, which has been slashing costs as it recovers from the rapid decline of its Covid business and stock price.

CNBC - 1d

Healthy Returns: Why people quit weight loss, diabetes drugs within one year

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to focus on GLP-1 products.

CNBC - 2d

Regeneron’s earnings boosted by more than doubling of U.S. sales of blockbuster eye drug Eylea

Regeneron Pharmaceuticals Inc.’s stock rose 4.9% Tuesday to put it on track for its biggest one-day gain in almost two years, after the company posted better-than-expected fourth-quarter earnings, ...

MarketWatch - 2d

Pfizer’s stock falls despite fourth-quarter revenue and earnings beat. This analyst expects growth to accelerate.

Pfizer Inc. shares fell 2% Tuesday despite the drugmaker topping Wall Street’s revenue and profit estimates in its fourth-quarter results.

MarketWatch - 2d

Weight Loss Drugs and Their Lesser Known Side Effects on Relationships

Doctors warn about their physical side effects, but they can also have unexpected effects on intimacy.

The New York Times - 4d

Lilly scores 34, Brown beats Pennsylvania 88-79

The Brown Bears defeated the Pennsylvania Quakers 88-79 on Friday night led by Kino Lilly Jr.'s 34 points

ABC News - 5d

Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir

CNBC's Jim Cramer on Friday walked investors through an earnings-heavy week.

CNBC - 5d

Americans split on using weight loss drugs to treat obesity: Survey

Americans are split on using weight loss drugs such as Ozempic and Wegovy to treat obesity or weight-related conditions, according to a survey published Friday. The new Associated Press (AP)-NORC ...

The Hill - 5d

Apple reports sagging iPhone sales in China as first-quarter earnings barely beat Wall Street’s expectations

Investors pay close attention to tech company’s foray into AI after Apple Intelligence’s glitches and inaccuracies. Apple slightly beat analysts’ expectations in its first-quarter earnings for ...

The Guardian - 6d

Sherwin-Williams sales fall short of estimates in choppy market, but stock perks up

Paint giant Sherwin-Williams offered soft guidance for the first quarter and for all of 2025.

MarketWatch - Jan. 30

IBM shares rise 9% on earnings beat

In a statement, IBM CEO Arvind Krishna said the company has recorded $5 billion in bookings for its generative AI business.

CNBC - Jan. 29

GM stock falls even as company beats analyst expectations on earnings

While investors will be watching GM's quarterly results, they will also be focused on its guidance for 2025 and any changes under the Trump administration.

CNBC - Jan. 28

Pharmacists issue warning over weight-loss jab sales

Pharmacists say they are aware of people being wrongly prescribed weight-loss drugs.

BBC News - Jan. 27

Increase regulation of online sale of weight-loss jabs, pharmacists say

Current rules leave door open for medicines to be supplied without appropriate patient consultation, association says. Pharmacies are demanding tougher regulation of the online sale of weight-loss ...

The Guardian - Jan. 27

No. 19 UConn falls short in 76-72 loss to Xavier

Dailyn Swain and Zach Freemantle each scored 15 points to help Xavier defeat No. 19 UConn 76-72 on Saturday night.

Yahoo Sports - Jan. 26

Novo Nordisk shares pop on early-stage weight loss drug trial results

The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.

CNBC - Jan. 24

American Airlines shares tumble as outlook falls short

American forecast a wider than expected loss for the first quarter, sending shares lower.

CNBC - Jan. 23

Travelers withstands higher catastrophe losses as underwriting fuels earnings beat

Travelers Cos. executives confirm the Los Angeles wildfires will have a material impact on the insurer’s first-quarter earnings but say it’s too soon to specify the costs.

MarketWatch - Jan. 22

Irish loss 'falls on my shoulders,' Freeman says

Following a 34-23 loss to Ohio State in Monday's College Football Playoff title game, Notre Dame coach Marcus Freeman told reporters, "We can't make mistakes. It falls on my shoulders. And as the ...

ESPN - Jan. 21

Weight-loss jabs linked to reduced risk of 42 conditions including dementia

Psychotic disorders also among conditions found less likely when people with diabetes took medications found in jabs. People with diabetes taking medications found in weight-loss jabs have a ...

The Guardian - Jan. 20

Weight-loss drugs may boost health in many ways, say researchers

New weight-loss drugs have broad health benefits but also come with risks, researchers warn.

BBC News - Jan. 20

Nets bounce back after historic loss but fall short to Lakers, 102-101

Austin Reaves scored a career-high 38 points, LeBron James had 29 and the Los Angeles Lakers held on to beat the Brooklyn Nets 102-101 on Friday night.

Yahoo Sports - Jan. 18

White House says popular weight-loss drug Ozempic subject to Medicare talks

Analysts at Argus Research say the stock is now trading at 22 times its estimated 2025 earnings.

MarketWatch - Jan. 17

Medicare announces weight-loss drugs, including Ozempic, will be up for price negotiations

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.

NBC News - Jan. 17

Fearnley falls short against second seed Zverev

Jacob Fearnley sees his encouraging Australian Open run come to an end against Alexander Zverev in the third round.

BBC News - Jan. 17

Medicare to Negotiate Lower Prices for Weight-Loss Drugs

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.

The New York Times - Jan. 17

Biden administration falls short on finalizing sage-grouse protections

The Biden administration took steps Thursday to safeguard an iconic bird species of the Western United States — but did so in only two out of the 10 states where such protections were anticipated. ...

The Hill - Jan. 16

Eli Lilly CEO expects new weight loss pill to be approved next year

Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which dominate the weight loss drug market.

CNBC - Jan. 13

Eli Lilly strikes deal for cancer treatment, gives timeline for weight loss pill

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.

CNBC - Jan. 13

What we learned as short-handed Warriors fall to red-hot Pacers

Pat Spencer and Buddy Hield combined to score 34 points, but it wasn't enough as the short-handed Golden State Warriors ran out of gas against the Indiana Pacers on Friday night.

Yahoo Sports - Jan. 11

High cost of weight loss drugs drives employers to require nutrition counseling, in boost for startups

Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss management program.

CNBC - Jan. 10

Medicare can now cover Eli Lilly's Zepbound for sleep apnea, Health Department agency says

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other insurance plans for weight loss.

CNBC - Jan. 9

Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.

NBC News - Jan. 9

Medicare can cover Zepbound for sleep apnea, creating a significant opportunity for Eli Lilly

Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment costs about $1,000 a month without insurance.

MarketWatch - Jan. 9

As Art Sales Fall, Christie’s and Sotheby’s Pivot to Luxury

With both supply and demand for big-ticket art in a slump, Sotheby’s and Christie’s are making major bets on selling handbags, classic cars and niche experiences.

The New York Times - Jan. 9

Smith dumps Diageo stake over impact of weight-loss drugs on alcohol demand

Veteran stockpicker sells shares in spirits brand because drinks sector is being ‘impacted negatively’

Financial Times - Jan. 9

Eli Lilly's lead in the obesity race has grown. Its recent stock performance says otherwise

Eli Lilly has been one of the worst-performing Club stocks over the past six months.

CNBC - Jan. 8

Latest in Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short

Topics